Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for posttraumatic stress disorder (PTSD).
For more information, please visit www.recoverystudy.com or www.clinicaltrials.gov (NCT03841773).

Tonix Pharmaceuticals is also enrolling participants in a Phase 3 trial for fibromyalgia.
For more information, please visit www.thereliefstudy.com or www.clinicaltrials.gov (NCT04172831).

SEC Filings
: All SEC Filings

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
12/04/19 4 Lederman Seth 2
12/03/19 8-K Current report filing
Related Documents
5
12/02/19 PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition 98
11/27/19 8-K Current report filing
Related Documents
182
11/25/19 SC 13G Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 9
11/25/19 SC 13G Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 10
11/22/19 8-K Current report filing
Related Documents
8
11/20/19 8-K Current report filing
Related Documents
5
11/18/19 424B4 Prospectus filed pursuant to Rule 424(b)(4) 41
11/15/19 8-K Current report filing
Related Documents
59